<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lifestyle interventions including exercise programs are cornerstones in the prevention of <z:hpo ids='HP_0001513'>obesity</z:hpo>-related <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>-activated protein kinase (AMPK) has been proposed to be responsible for many of the beneficial effects of exercise on <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism </plain></SENT>
<SENT sid="2" pm="."><plain>The effects of long-term exercise training or 5-<z:chebi fb="0" ids="22512">aminoimidazole</z:chebi>-4-<z:chebi fb="0" ids="23004,37622">carboxamide</z:chebi>-1-beta-d-riboruranoside (AICAR) treatment, both known AMPK activators, on the development of <z:mp ids='MP_0002055'>diabetes</z:mp> in male <z:chebi fb="3" ids="16646">Zucker</z:chebi> diabetic fatty (ZDF) rats were examined </plain></SENT>
<SENT sid="3" pm="."><plain>Five-week-old, <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> ZDF rats underwent daily treadmill running or AICAR treatment over an 8-week period and were compared with an untreated group </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast to the untreated, both the exercised and AICAR-treated rats did not develop <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> during the intervention period </plain></SENT>
<SENT sid="5" pm="."><plain>Whole-body insulin sensitivity, as assessed by a hyperinsulinemic-euglycemic clamp at the end of the intervention period, was markedly increased in the exercised and AICAR-treated animals compared with the untreated ZDF rats (P &lt; 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, pancreatic beta-cell <z:mp ids='MP_0000002'>morphology</z:mp> was almost <z:mpath ids='MPATH_458'>normal</z:mpath> in the exercised and AICAR-treated animals, indicating that <z:hpo ids='HP_0011010'>chronic</z:hpo> AMPK activation in vivo might preserve beta-cell function </plain></SENT>
<SENT sid="7" pm="."><plain>Our results suggest that activation of AMPK may represent a therapeutic approach to improve insulin action and prevent a decrease in beta-cell function associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>